Home › Uterine Cancer › Ohio › Cleveland
Uterine Cancer clinical trials in Cleveland, OH
3 studies for Uterine Cancer are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- and 3 more
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
RecruitingPhase 1
- UH Cleveland Medical Center, Cleveland
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
- Research Site, Cleveland
- Research Site, Cleveland
About Uterine Cancer
Uterine cancer is a cancer that forms in tissues of the uterus. It is more likely to happen after menopause. There are things you can do that may help lower your risk.
More about Uterine Cancer on MedlinePlus
Uterine Cancer trials in other cities
- Houston, TX8 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Columbus, OH6 studies
- Austin, TX6 studies
- Philadelphia, PA6 studies
- Miami, FL5 studies
- Nashville, TN5 studies
- Orlando, FL4 studies
- Pittsburgh, PA4 studies
- West Palm Beach, FL4 studies
- Providence, RI4 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Heart Failure31 studies
- Metastatic Cancer30 studies
- Prostate Cancer30 studies
- Ovarian Cancer29 studies
- Lung Cancer26 studies
- Colorectal Cancer25 studies
- Acute Myeloid Leukemia20 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Cardiovascular Disease20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.